Creative Planning

Position in EBS — Emergent BioSolutions Inc.

CIK 1540235 OVERLAND PARK, KS

Position in EBS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$501,517

+$223,102 QoQ

Shares Held

59,847

+78.4% QoQ

Ownership

0.117%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#68

of 194 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Creative Planning holds $137,414,626 across 41 Drug Manufacturers - Specialty & Generic names. EBS ranks #30 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	1,240,848	$17,979,887
2	UTHR	UNITED THERAPEUTICS Corp	28,934	$15,677,309
3	VTRS	Viatris Inc	920,607	$14,619,238
4	NBIX	Neurocrine Biosciences Inc	76,818	$12,946,905
5	LNTH	Lantheus Holdings, Inc.	85,571	$9,493,246
6	TAK	Takeda Pharmaceutical Co Ltd	584,777	$9,373,974
7	ZTS	Zoetis Inc.	121,209	$8,710,078
8	HIMS	Hims & Hers Health, Inc.	225,206	$7,807,891

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$501,517	59,847	+78.4%	Shares	Defined	2026-08-13
2026-03-31	$278,415	33,544	+17.5%	Shares	Sole	2026-05-12
2025-12-31	$352,853	28,548	+31.3%	Shares	Sole	2026-02-17
2025-09-30	$191,763	21,742	+44.7%	Shares	Defined	2025-11-14
2025-06-30	$95,853	15,024	+3.8%	Shares	Sole	2025-08-08
2025-03-31	$70,314	14,468	-9.6%	Shares	Sole	2025-05-15
2024-12-31	$152,960	16,000	-2.7%	Shares	Sole	2025-02-14
2024-09-30	$137,290	16,442	-7.5%	Shares	Sole	2024-10-11
2024-06-30	$121,177	17,768	+26.5%	Shares	Sole	2024-08-15
2024-03-31	$35,541	14,048	+195.8%	Shares	Sole	2024-05-13
2021-06-30	$299,139	4,749	+34.2%	Shares	Sole	2021-08-04
2021-03-31	$328,808	3,539	-74.1%	Shares	Sole	2021-04-30
2020-12-31	$1,223,756	13,658	+134.5%	Shares	Sole	2021-01-29
2020-09-30	$601,897	5,825	—	Shares	Sole	2020-11-05
No filing history on record for this holder in this stock.